Dr. Reddy's (RDY) Financial Analysis & Valuation | Quarter Chart

Dr. Reddy's (RDY)

RDY
Price: $14.86
Fair Value: 🔒
🔒score
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics... more
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pha... more
Description Shares
Market Cap$12.37BExchangeNYSE
SectorHealthcareIndustryDrug Manufacturers - Specialty & Generic
CountryINCEOErez Israeli
IPO Date2001-04-11CAGR0.15%
Employees27,048Websitewww.drreddys.com
Div. Yield0.6%Payout Ratio0.16%
Buy Back Yield—Total Yield0.6%
RDY chart loading...
Fundamentals Technicals
Enterprise Value$1142.00BP/E Ratio24.36
Forward P/E0.23PEG Ratio-0.32
P/S Ratio3.32P/B Ratio2.98
P/CF Ratio20.36P/FCF Ratio47.33
EPS$0.61EPS Growth 1Y-24.06%
EPS Growth 3Y-81%EPS Growth 5Y-55.31%
Revenue Growth 1Y3.55%Gross Margin0.53%
Operating Margin0.15%Profit Margin0.13%
ROE0.12%ROA0.07%
ROCE0.12%Current Ratio1.8
Quick Ratio1.35Cash Ratio0.09
Debt/Equity0.21Interest Coverage13.29
Altman Z Score5.37Piotroski Score4

View Dr. Reddy's financial charts →